Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.
Authors: Lin S; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Liao T; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Fan F; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China., Chen Y; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China., Yan Y; China-Japan Friendship Hospital, Beijing, China., Dong H; Nanfang Hospital Southern Medical University, Guangzhou, China., Zhan S; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Zhang Y; Jiangxi Provincial Hospital of Chinese Medicine, Nanchang, China., Xiao K; The Second People's Hospital of Baiyun and Guangzhou, Guangzhou, China., Lin L; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China., Wu L; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 May 25; Vol. 17, pp. 1775068. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42266370
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating Cordyceps militaris capsules on post-bronchodilator FEV<subscript>1</subscript> decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+S%22">Lin S</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Liao+T%22">Liao T</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Fan+F%22">Fan F</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Yan+Y%22">Yan Y</searchLink>; China-Japan Friendship Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Dong+H%22">Dong H</searchLink>; Nanfang Hospital Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhan+S%22">Zhan S</searchLink>; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Jiangxi Provincial Hospital of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Xiao+K%22">Xiao K</searchLink>; The Second People's Hospital of Baiyun and Guangzhou, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+L%22">Lin L</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+L%22">Wu L</searchLink>; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 May 25; Vol. 17, pp. 1775068. <i>Date of Electronic Publication: </i>2026 May 25 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42266370
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2026.1775068
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1775068
    Titles:
      – TitleFull: Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin S
      – PersonEntity:
          Name:
            NameFull: Liao T
      – PersonEntity:
          Name:
            NameFull: Fan F
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Yan Y
      – PersonEntity:
          Name:
            NameFull: Dong H
      – PersonEntity:
          Name:
            NameFull: Zhan S
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Xiao K
      – PersonEntity:
          Name:
            NameFull: Lin L
      – PersonEntity:
          Name:
            NameFull: Wu L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 05
              Text: 2026 May 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1